SEC Form 4 · accession 0001638599-16-000624
ALBANY MOLECULAR RESEARCH INC · AMRI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Felicia I Ladin
Officer — CFO
Period of report
Feb 4, 2016
Accepted (ET)
Feb 8, 2016 · 5:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001065087
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 4, 2016 | A | 13,792 | $15.77 | A | 47,616 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $15.77 | Feb 4, 2016 | A | 31,609 | A | — | Feb 4, 2026 | Common Stock | 31,609 | 31,609 | D |
Explanation of responses
- F1Option that is exercisable as to 1/4th of the shares annually on the anniversary date of the grant for each of the next four years.